Sam Brusco, Associate Editor11.08.23
GE HealthCare and Masimo began a joint agreement to integrate Masimo Signal Extraction Technology (SET) pulse oximetry into GE HealthCare Portrait Mobile wireless and wearable patient monitoring solution.
Portrait Mobile, which GE HealthCare calls an Internet of Medical Things (IoMT) platform, was cleared by the U.S. Food and Drug Administration (FDA) in August. It uses cloud native technology for real-time, continuous monitoring with a personalized view of patient vitals. It also keep patients mobile during recovery periods, particularly after surgery or discharge from the intensive care unit (ICU).
Last month, GE HealthCare released positive data from the 100-patient COSMOS pilot study of Portrait Mobile with the Cleveland Clinic.
“Portrait Mobile is built as an open platform, with the capability to be compatible with other technologies. The ability to integrate Masimo's innovative SET pulse oximetry in a wearable sensor demonstrates the flexibility and scalability of our new platform while leveraging Masimo’s measurement expertise,” GE HealthCare’s GM of monitoring solutions Neal Sandy told the press. “Clinicians and patients will see the real benefit as Portrait Mobile enhances clinical decision-making for mobile patients and ultimately, supports earlier detection of deterioration."
Adding Masimo’s SET to Portrait Mobile grants the system Motion and Low Perfusion SpO2 measurement tech, which noninvasively detects and continuously monitors patients’ status changes. The duo believes this added functionality will be especially useful for critical recovery period—after surgery or discharge from the intensive care unit.
“We are excited to build on our collaboration with GE HealthCare by providing integrated solutions to help our customers and optimize patient care,” said Masimo COO Bilal Muhsin. “Through our expansion into mobile, wireless technologies, we are proud to incorporate Masimo SET pulse oximetry into the Portrait Mobile monitoring solution.”
Portrait Mobile, which GE HealthCare calls an Internet of Medical Things (IoMT) platform, was cleared by the U.S. Food and Drug Administration (FDA) in August. It uses cloud native technology for real-time, continuous monitoring with a personalized view of patient vitals. It also keep patients mobile during recovery periods, particularly after surgery or discharge from the intensive care unit (ICU).
Last month, GE HealthCare released positive data from the 100-patient COSMOS pilot study of Portrait Mobile with the Cleveland Clinic.
“Portrait Mobile is built as an open platform, with the capability to be compatible with other technologies. The ability to integrate Masimo's innovative SET pulse oximetry in a wearable sensor demonstrates the flexibility and scalability of our new platform while leveraging Masimo’s measurement expertise,” GE HealthCare’s GM of monitoring solutions Neal Sandy told the press. “Clinicians and patients will see the real benefit as Portrait Mobile enhances clinical decision-making for mobile patients and ultimately, supports earlier detection of deterioration."
Adding Masimo’s SET to Portrait Mobile grants the system Motion and Low Perfusion SpO2 measurement tech, which noninvasively detects and continuously monitors patients’ status changes. The duo believes this added functionality will be especially useful for critical recovery period—after surgery or discharge from the intensive care unit.
“We are excited to build on our collaboration with GE HealthCare by providing integrated solutions to help our customers and optimize patient care,” said Masimo COO Bilal Muhsin. “Through our expansion into mobile, wireless technologies, we are proud to incorporate Masimo SET pulse oximetry into the Portrait Mobile monitoring solution.”